Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fetal and Infant Effects of Maternal Buprenorphine Treatment
NCT01561079Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2012
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of buprenorphine in opioid use disorder (OUD), sponsored by Johns Hopkins University. Primary endpoints: Fetal Heart Rate, Fetal Heart Rate Variability and 3 more. Started Feb 2012; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01561079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561079.